The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices

BACKGROUND: To date there exist no internationally recognised Good Manufacturing Practices (GMP) that clearly outline universally accepted standards for manufacturing highly active or sensitising ingredients. The pharmaceutical industry is faced with a twofold problem: determining which drugs need d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fabio, Petrelli, Alessandro, Caraffa, Stefania, Scuri, Iolanda, Grappasonni, Elena, Magrini, Aldo, Cocchini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776210/
https://www.ncbi.nlm.nih.gov/pubmed/31125009
http://dx.doi.org/10.23750/abm.v90i2.8340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776210/
https://www.ncbi.nlm.nih.gov/pubmed/31125009
http://dx.doi.org/10.23750/abm.v90i2.8340

Ejemplares similares